Top compounds associated with response to EIF2B3


Feature Type Standardized
Nominal ANOVA
mRNA neratinib CTRPv2 pan-cancer AAC -0.092 0.01
mRNA Doxorubicin gCSI pan-cancer AAC 0.13 0.01
mRNA Topotecan CCLE pan-cancer AAC 0.11 0.01
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.14 0.01
mRNA TAE684 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA AEW541 CCLE pan-cancer AAC -0.12 0.01
mRNA CAY10603 GDSC1000 pan-cancer AAC 0.08 0.01
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.27 0.01
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.086 0.01
Download CSV